US 9308249
Norovirus vaccine formulations
granted A61KA61K2039/5258A61K2039/54
Quick answer
US patent 9308249 (Norovirus vaccine formulations) held by Takeda Vaccines, Inc. expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Vaccines, Inc.
- Grant date
- Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 41
- CPC classes
- A61K, A61K2039/5258, A61K2039/54, A61K2039/543, A61K2039/55572